August 9, 2020 - 8:00 AM
August 11, 2020 - 5:00 PM
District of Columbia
Who Should Attend
Attendance is limited to 600 HIV physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs. A limited number of spots are reserved for RNs and PharmDs who are the primary clinical decision makers in their RWHAP-funded clinics or programs.
Attendance to this 2020 CLINICAL CONFERENCE is limited, and all attendees must be approved. Please do not book hotel accommodations or make travel arrangements prior to receiving notification that your application to attend has been approved.
** If you do not receive an application status notification within 2 business days of submitting your application, please check your spam folder. Otherwise, please email email@example.com.
2020 CLINICAL CONFERENCE Description
The 2020 CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.
The 2020 CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the three days of the 2020 CLINICAL CONFERENCE. It will conclude immediately before the opening general session of the National Conference.
The educational objectives for the 2020 CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.
On completion of the 2020 CLINICAL CONFERENCE, participants will be able to:
- Describe the new aspects to the Ryan White HIV/AIDS Program
- Identify situations in which the choice of antiretroviral regimen should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
- Describe the most current data on currently available and investigational new antiretroviral drugs, formulations, and strategies
- Initiate and monitor HIV prevention intervention strategies, including the use of preexposure prophylaxis (PrEP), in individuals at risk for HIV infection
- Incorporate selected aspects of primary care for individuals with HIV infection, especially in the aging population, which may include:
- Screening for cancer
- Sexually transmitted infections and opportunistic infections screening, treatment, and prevention
- Renal disease
- Cardiovascular disease
- Bone disease
- Endocrine disorders
- Neurocognitive disorders
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is eligible for AMA PRA Category 1 Credits™; see the final activity announcement for details.
ABIM MOC Points
This activity is eligible for ABIM MOC Points; see the final activity announcement for details.
American Academy of Family Physicians Credits
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
This activity is eligible for ANCC credit; see the final CNE activity announcement for specific details.
This activity is eligible for ACPE credit; see the final CPE activity announcement for specific details.
This conference is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to International Antiviral Society–USA (IAS–USA) to sponsor this CME activity. There is no registration fee to attend. Attendees are responsible for their transportation expenses to and from Washington, DC, hotel stay costs, meals, and all other expenses. Please check with your project officer about expenses that are covered by your RWHAP award.